Background: Transient hyperthyroidism of hyperemesis gravidarum (TIlHG) is a self-limiting hyperthyroidism occurring in the context of hyperemesis gravidarum.
Transient hyperthyroidism of hyperemesis gravidarum (THHG) is a self-limiting hyperthyroidism occurring in the context of hyperemesis gravidarum. Thyroid function tests in THHG can be indistinguishable from those seen in pathologic causes of hyperthyroidism such as Graves disease. Including THHG in the differential diagnosis of hyperthyroidism in pregnancy can prevent unnecessary treatment or referrals.
Methods
A case report of a woman with THHG is described, and a literature search of MEDLINE was undertaken. THHG has been only tangentially described in the family practice literature. 1 The following case report describes a classic case of THHG. A discussion of the clinical findings and diagnosis of THHG ensues. The incidence, mechanism, natural history, and treatment of this condition are also described.
Case Report
A 32-year-old woman, gravida 4, para 2, came to the emergency department with a chief complaint of 2 weeks of emesis, 5 to 6 episodes per day. She felt lightheaded and noted a decrease in both volume and frequency of urination. She had a normal menstrual period 10 weeks before her visit and a positive pregnancy test 3 weeks earlier. She denied nervousness, diaphoresis, heat intolerance, hyperactivity, tremor, weakness, and diarrhea both before and during this pregnancy.
Her obstetric history was notable for two fullterm, vaginal deliveries and a first-trimester miscarriage. She had been hospitalized for hyperemesis early in the course of her first full-term pregnancy. She had no personal or family history of thyroid disease or autoimmune disorders.
Her supine pulse was 98 mm Hg that increased to 114 mm Hg when standing. Her weight was 10 pounds less than her prepregnancy weight of 125 pounds. She had dry oral mucosa and a slightly enlarged uterus. She had no palpable thyroid abnormalities and no proptosis.
Her urine pregnancy test was positive. Results of a urinalysis were a specific gravity of 1.030 and increased ketones. Serum chemistry was notable for a slightly decreased potassium level of 3.4 mEqlL (lower limit of normal 3.5 mEqlL) and decreased bicarbonate of 21 mEqlL (lower limit of normal 24 mEqlL).
A pelvic sonogram confirmed a single, intrauterine pregnancy of 10 weeks and 3 days' gestation. Her condition was diagnosed as hyperemesis gravidarum and treated with volume replacement and antiemetics. Thyroid function studies were done to rule out hyperemesis secondary to hyperthyroidism. Her initial thyroid-stimulating hormone (TSH) level was <0.06 f.LU/mL (lower limit of normal, 0.32 f.LU/mL) and free thyroxine (T4) level was 4.16 ng/dL (upper limit of normal, 2.5 ng/dL). Because the thyroid function studies were consistent with hyperthyroidism, she was referred for treatment of hyperthyroidism in pregnancy.
Since neither her prepregnancy history nor initial findings showed signs or symptoms of hyperthyroidism, an alternative diagnosis of THHG was considered. Further laboratory data showed an elevated free triiodothyronine (T3) level of 674 pg/dL (upper limit of normal, 420 pg/dL). An anti-TSH receptor antibody titer was negative.
Given the absence of prepregnancy hyperthyroidism, the pattern of elevated thyroid function tests occurring in the context of hyperemesis, the lack of stigmata of hyperthyroidism, and absence of anti-TSH receptor antibodies, a diagnosis of THHG was made. Supportive treatment for hyperemesis was continued. Her symptoms had resolved by 15 weeks' estimated gestational age. TSH, free T 3 and free T 4 levels returned to normal shortly thereafter. She gave birth to a healthy infant at term.
Discussion

Evaluatiml and Diagnosis
Hyperemesis gravidarum is a condition of persistent and excessive vomiting developing in early pregnancy that can be distinguished from common nausea and vomiting of pregnancy by considerable 36 JABFP January-February 2000 Vol. Although hyperemesis in pregnancy is typically self-limiting, it can also be secondary to a multiple gestation, molar pregnancy, cholecystitis, pyelonephritis, pancreatitis, hepatitis, and, rarely, hyperthyroidism. 3 A focused history, physical examination, and laboratory evaluation can usually rule out abnormalities of the gallbladder, liver, kidney, and pancreas, and obstetric sonography can rule out multiple gestations and molar pregnancy.
Thyroid function studies can rule out hyperthyroidism, as they did in this case. In a normal pregnancy, thyroid-binding globulin levels are elevated above nonpregnant levels because of estrogenstimulated synthesis. As a result, total T3 and T4 levels are elevated, but biochemically active free T 3 and free T 4 levels are within normal limits. In contrast, pathologic hyperthyroidism (eg, secondary to Graves disease) is marked by elevated free T3 and free T 4 and suppressed TSH levels. The same pattern of thyroid function abnormalities occurs in THHG ( Table 1) .
Because it is impossible to distinguish pathologic hyperthyroidism from THHG by thyroid function tests alone, the diagnosis of THHG rests on four criteria:
Abnormal thyroid function tests developing in the context of hyperemesis gravidarum
By definition, THHG develops in the context of hyperemesis gravidarum. Thyroid function abnormalities that precede the development of hyperemesis gravidaurm or persist after its resolution should trigger a search for alternative diagnoses.
No evidence of prepregnancy hyperthyroidism
The possibility that abnormal thyroid function tests could indicate previously undiagnosed hyperthyroidism can be ruled out by a thorough prepregnancy review of systems. Graves disease, the most common cause of pathologic hyperthyroidism in women of childbearing age, only rarely develops in pregnancy; most patients with Graves disease will have symptoms that predate their pregnancy.4 Patients with THHG, in contrast, will have no prepregnancy symptoms. 5 This review of symptoms of hyperthyroidism should include nervousness, sweating, heat intolerance, hyperactivity, tremor, weakness, diarrhea, tachycardia, and increased appetite. 6 A history of hyperemesis in previous pregnancies, however, as in this case, is often found in patients with THHG. 5 
Absence of physical examination findings consistent with hyperthyroidism
Whether because of the brief or mild nature of the hyperthyroidism ofTHHG, the classic physical examination findings associated with hyperthyroidism are not seen. 2 ,7 These include goiter, lid lag, onycholysis, proximal muscle weakness, and the exophthalmos of Graves disease. Patients with THHG might, however, have a mild resting tachycardia and mild tremor. 5 
Negative thyroid autoantibody titers
Graves disease can be ruled out by evaluation of thyroid autoantibody titers. Antithyroid peroxidase and anti-TSH receptor antibodies are often positive in Graves disease but negative in THHG (Table 1).5
Incidence
There are no published reports on the incidence of THHG. An estimate can be extrapolated from data on hyperemesis gravidarum and from the relatively small case series reports on THHG. Hyperemesis gravidarum occurs in about 1 in 2000 pregnancies. s The largest published case series of THHG found evidence of hyperthyroidism consistent with THHG in approximately 70% of cases of hyperemesis gravidarum.
2 Based on these data, THHG might occur in up to 0.7 of 2000 pregnancies.
Separate data put the incidence of thyrotoxicosis in pregnancy at 1 in 2000. 9 It is unclear whether THHG is included in this figure. If not, then THHG could account for 40% of hyperthyroidism in pregnancy. If included, THHG accounts for 70% of cases of hyperthyroidism in pregnancy.
Mechanism
Since the association between hyperemesis gravidarum and biochemical markers of hyperthyroidism was first described in 1982,10 investigation into the mechanism of THHG has focused on the role of human chorionic gonadotropin. Chorionic gonadotropin is known to act directly on TSH receptors to stimulate excess hormone production. Through a separate pathway, it could also act to increase estradiol levels that in turn trigger vomitingY Further studies have focused on an asialo subtype of chorionic gonadotropin that appears to have an increased affinity for TSH receptors. 12 Additionally, a mutation in the TSH receptor conferring hypersensitivity to chorionic gonadotropin could play a role in some cases of THHG.13 As chorionic gonadotropin levels in pregnancy naturally decline in the second trimester, both hyperemesis and thyroid function abnormalities of THHG resolve.
Natural History and Treatment
THHG is a self-limiting condition. Thyroid function tests typically return to normal by 18 weeks' estimated gestational age, although emesis can persist beyond 18 weeks. 2 No treatment is required other than supportive care for the symptoms and consequences (eg, volume depletion) associated with hyperemesis gravidarum. There is no evidence of adverse outcomes in pregnancies complicated by THHG, and there is no evidence that treatment with antithyroid medications (eg, propylthiouracil) is warranted, although its use has been described in isolated case reports. Thyroid function tests can be repeated until they return to normal.
Conclusion
THHG is a benign condition masquerading as pathologic hyperthyroidism. Diagnosis is based on (1) abnormal thyroid function tests developing in the context of hyperemesis gravidarum, (2) no evidence of prepregnancy hyperthyroidism, (3) absence of physical examination findings consistent with hyperthyroidism, and (4) negative thyroid autoantibody titers (antithyroid peroxidase and TSHreceptor antibodies). Diagnosis and management are well within the scope of care provided by the family physician.
